Scinai Immunotherapeutics Ltd. (SCNI)
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
Address
JERUSALEM BIOPARK, 2ND FLOOR
JERUSALEM, L3 00000
Founded
2003
Number of Employees
31
Website
http://www.scinai.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)